AnalystBook Research · Company Intelligence

AdvanSix Inc.

ASIXNYSE

Built from AdvanSix Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

AdvanSix net income rose 11.6% to $49.3M and FCF rebounded to $6.4M, while cash from ops fell and insiders were sellers.

The read at a glance✓ Audited against SEC data
  • Business mixNylon, plant nutrients, and chemical intermediatesNote
  • ProfitabilityNet income rose 11.6%OK
  • CashCash from ops fell 9.3%Watch
  • FCFFCF rose to $6.4MOK
  • Capital return$17.2M dividends; $1.7M buybacksNote
  • Insiders0 buys / 3 sellsWatch
  • AccountingLatest EQ safeNote

Business

AdvanSix is an industrial chemical company with tagged product rows for Plant Nutrients, Chemical Intermediates, Nylon Resins, and Caprolactam.

Where the revenue comes from

Fiscal 2025, as AdvanSix Inc. reports it. History and quarterly detail are in the app.

  • Plant Nutrients$563.7M
  • Chemical Intermediates$377.5M
  • Nylon$309.7M
  • Caprolactam$271.4M

Leadership changes

From AdvanSix Inc.'s own filings, the day they're filed.

  • Patrick C. Day · President · appointmenteff. 2026-04-13
  • Jeffrey J. Bird · Director · appointmenteff. 2026-01-01
  • Dana O'Brien · Directors · appointmenteff. 2025-09-02

Latest filings

  • 8-K · Company announcement2026-08-17
  • 8-K · Company announcement2026-08-07
  • 10-Q · Quarterly report2026-08-07
  • 8-K · Company announcement2026-06-23
  • 10-Q · Quarterly report2026-05-08
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about AdvanSix Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.